Bcl-2 Retards Cell Cycle Entry through p27 super(Kip1), pRB Relative p130, and Altered E2F Regulation

• Published in: Molecular and cellular biology 2000-07, Vol.20 (13), p.4745-4753
• Main Authors: Vairo, G, Soos, T J, Upton, T M, Zalvide, J, DeCaprio, JA, Ewen, ME, Koff, A, Adams, J M
• Format: Article
• Language: English
• Subjects: E2F gene; E2F protein; E2F1 gene; E2F4 protein; Kip1 gene; p130 protein; p27 protein; p27Kip1 protein; retinoblastoma protein
• ISSN: 0270-7306
• DOI: 10.1128/MCB.20.13.4745-4753.2000

Independent of its antiapoptotic function, Bcl-2 can, through an undetermined mechanism, retard entry into the cell cycle. Cell cycle progression requires the phosphorylation by cyclin- dependent kinases (Cdks) of retinoblastoma protein (pRB) family members to free E2F transcription factors. We have explored whether retarded cycle entry is mediated by the Cdk inhibitor p27 or the pRB family. In quiescent fibroblasts, enforced Bcl-2 expression elevated levels of both p27 and the pRB relative p130. Bcl-2 still slowed G sub(1) progression in cells deficient in pRB but not in those lacking p27 or p130. Hence, pRB is not required, but both p27 and p130 are essential mediators. The ability of p130 to form repressive complexes with E2F4 is implicated because the retardation by Bcl-2 was accentuated by coexpressed E2F4. A plausible relevant target of p130/E2F4 is the E2F1 gene, because Bcl-2 expression delayed E2F1 accumulation during G sub(1) progression and overexpression of E2F1 overrode the Bcl-2 inhibition. Hence, Bcl-2 appears to retard cell cycle entry by increasing p27 and p130 levels and maintaining repressive complexes of p130 with E2F4, perhaps to delay E2F1 expression.